Kr. Petersen et al., Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives, FIBRINOL PR, 14(5), 2000, pp. 315-321
Objective: To study why the plasma antigen concentrations of tissue-plasmin
ogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) ar
e reduced in users of oral contraceptives (OCs).
Design: Open, non-randomized study.
Setting: University departments in Copenhagen and Esbjerg, Denmark.
Subjects: Sixteen healthy female volunteers between 21 and 32 years of age.
Eight women used an OC containing ethinyl estradiol and gestodene (OC grou
p) and eight women used non-hormonal contraception (control group).
Intervention: Determination of splanchnic plasma flow and total plasma volu
me; measurement of t-PA and PAI-1 antigen as well as active t-PA and PAI-1
in plasma from an artery and a liver vein
Main outcome measures: Extraction, clearance, net rate of catabolism and me
an transit time of t-PA and PAI-1 in the splanchnic circulation.
Results: Arterial plasma concentrations of t-PA and PAI-1 antigen were redu
ced in the OC group whereas the concentrations of active t-PA and active PA
I-1 were similar. The arterio-venous (A-V) difference for t-PA antigen and
active t-PA was positive in both groups. The net splanchnic catabolism of t
-PA antigen was reduced in the OC group, while the extraction, clearance an
d mean transit time were similar. The extraction, clearance, net rate of ca
tabolism and mean transit time of active t-PA did not differ between the tw
o groups. For PAI-1, differences in the main outcome measures between the t
wo groups could not be determined, as there was no statistically significan
t A-V difference for PAI-1 antigen in any of the groups and a significant A
-V difference for active PAI-1 in the control group only.
Conclusion: The reduced net splanchnic catabolism of t-PA antigen in the OC
users probably reflects a decreased peripheral synthesis of t-PA, which ma
y explain the low plasma concentration in these women. The mechanism underl
ying the reduced concentration of PAI-1 antigen in the OC users could not b
e determined by the present methodology. (C) 2000 Harcourt Publishers Ltd.